Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp - 04/02/24
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
The RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 plays a pivotal role in the life cycle of the novel coronavirus and stands as a significant and promising target for anti-SARS-CoV-2 drugs. Non-nucleoside inhibitors (NNIs), as a category of compounds directed against SARS-CoV-2 RdRp, exhibit a unique and highly effective mechanism, effectively overcoming various factors contributing to drug resistance against nucleoside inhibitors (NIs). This review investigates various NNIs, including both natural and synthetic inhibitors, that closely interacting with the SARS-CoV-2 RdRp with valid evidences from in vitro and in silico studies.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Keywords : SARS-CoV-2, RdRp, Non-nucleoside inhibitors, Natural products, Synthetic inhibitors
Plan
Vol 171
Article 116180- février 2024 Retour au numéro
Article précédent
- Interactions between miRNAs and the Wnt/β-catenin signaling pathway in endometriosis
- Yu Zhang, Xueyu Sun, Zhongkang Li, Xianhong Han, Wenjun Wang, Penglin Xu, Yangyang Liu, Yuna Xue, Zhe Wang, Shuling Xu, Xueying Wang, Gailing Li, Yanpeng Tian, Qian Zhao
- Cytisine: State of the art in pharmacological activities and pharmacokinetics
- Xuezhen Wang, Jiaming Yang, Peifeng Huang, Dong Wang, Zhibin Zhang, Zehua Zhou, Leiqin Liang, Rongmei Yao, Long Yang
Bienvenue sur EM-consulte, la référence des professionnels de santé.